FEBRUARY 11, 2012

Browse Categories

Error
  • Invalid access to download
Contribute to UroToday

Contribute to UroToday

Be a part of the published community of UroToday and promote awareness among your colleagues.

If you are interested in writing for UroToday Contact Us

editors@urotoday.com

Experience the new UroToday

UroToday has been free, providing open access to Urology content online since 2003. The challenging economic environment driving higher costs has resulted in our needing to charge for subscription access.  All sponsored content will remain free and open to readers.  We are committed to continue providing the highest quality, evidence-based urological information, keeping our subscribers up to date.


Uro Today
  • Improved access to key content
  • Dynamic user experience
  • Extensive archives dating back to 2003
Uro Today International Journal
  • Expeditious publishing
  • Engaging new media
  • Credible, international Editorial Board
Urotoday Exclusives

BERKELEY, CA (UroToday.com) - An Optimistic Take on Recent Onset BPS/IC  

Experience the new UroToday

UroToday has been free, providing open access to Urology content online since 2003. The challenging economic environment driving higher costs has resulted in our needing to charge for subscription access.  All sponsored content will remain free and open to readers.  We are committed to continue providing the highest quality, evidence-based urological information, keeping our subscribers up to date.


Uro Today
  • Improved access to key content
  • Dynamic user experience
  • Extensive archives dating back to 2003
Uro Today International Journal
  • Expeditious publishing
  • Engaging new media
  • Credible, international Editorial Board
CAUTI Challenge

CAUTI CHALLENGE TODAY (TM) is a part of your Urology Insights newsletter subscription. Access the latest commentary from CAUTI Expert Diane K. Newman, recent publications and experiences from those in the CAUTI treatment community.
Experience the new UroToday

UroToday has been free, providing open access to Urology content online since 2003. The challenging economic environment driving higher costs has resulted in our needing to charge for subscription access.  All sponsored content will remain free and open to readers.  We are committed to continue providing the highest quality, evidence-based urological information, keeping our subscribers up to date.


Uro Today
  • Improved access to key content
  • Dynamic user experience
  • Extensive archives dating back to 2003
Uro Today International Journal
  • Expeditious publishing
  • Engaging new media
  • Credible, international Editorial Board
UIJ

UroToday International Journal is a peer-reviewed, online publication featuring many types of articles about clinical urology and basic research in urology.
No Cost
There is no charge to submit, or publish an article in the UroToday International Journal. Additionally, there are no charges for color figures.
.....
Experience the new UroToday

UroToday has been free, providing open access to Urology content online since 2003. The challenging economic environment driving higher costs has resulted in our needing to charge for subscription access.  All sponsored content will remain free and open to readers.  We are committed to continue providing the highest quality, evidence-based urological information, keeping our subscribers up to date.


Uro Today
  • Improved access to key content
  • Dynamic user experience
  • Extensive archives dating back to 2003
Uro Today International Journal
  • Expeditious publishing
  • Engaging new media
  • Credible, international Editorial Board

Exclusive Headlines

WCE 2011 - Flexible ureteroscopy for renal stones >1cm - the method of choice? - Session Highlights

KYOTO, JAPAN (UroToday.com) - The improvement in ureteroscopic technology along with continued interest in retrograde intrarenal surgery (RIRS) has expanded the indications and boundaries for its use.

see full text
WCE 2011 - What should we measure? Predicting outcomes with flexible ureteroscopy for large renal stones - Session Highlights

KYOTO, JAPAN (UroToday.com) - In another study, factors predicting success rates for RIRS for large (>1cm) stones was evaluated.

see full text
WCE 2011 - Prospective evaluation of patient satisfaction with treatment outcomes after shock wave lithotripsy and ureteroscopy for ureteral stones - Session Highlights

KYOTO, JAPAN (UroToday.com) - In an interesting study by Jinsung Park and colleagues, 160 consecutive ureteral stone patients who underwent either shockwave lithotripsy (SWL, n=65) or ureteroscopy (URS, n=95) were evaluated for typical clinical outcomes.

see full text
WCE 2011 - The CROES Percutaneous Nephrolithotomy Global Study: Urinary tract infections and post-operative fever in percutaneous nephrolithotomy - Session Highlights

KYOTO, JAPAN (UroToday.com) - Percutaneous nephrolithotomy (PNL) is the established treatment for large renal calculi, yet concrete risk factors for postoperative complications, such as fever and blood transfusion, are still being delineated.

see full text

BJU Int Mini Reviews

UroToday News

Clinical efficacy of TroVax in the treatment of progressive castration-resistant prostate cancer - Abstract

With approximately 240,890 new cases expected in 2011, prostate cancer remains the leading cause of non-melanoma cancer deaths in men.

see full text
Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia - Abstract

High grade prostatic intraepithelial neoplasia (HGPIN) is a risk factor for prostate cancer (PCa), but only multifocality is an indication for early rebiopsy.

see full text
Will SBRT replace conventional radiotherapy in patients with low-intermediate risk prostate cancer? A review - Abstract

Stereotactic body radiation therapy (SBRT) is a novel treatment modality in radiation oncology that delivers a very high dose of radiation to the tumor target with high precision using single or a small number of fractions.

see full text
Does antibiotherapy prevent unnecessary prostate biopsies in patients with high PSA values? - Abstract

INTRODUCTION: We investigated if antibiotherapy has any role on total PSA (tPSA), free PSA (fPSA) and fPSA/tPSA ratio in patients with tPSA higher than 2.5ng/ml.

see full text

Share |